# MASTER-06 stage policy

Parent: 46539f4beb5cc79e3ff35f9d6a6f46086d3390b3. Continue the [MASTER-05 criteria](../master-05/STAGE_POLICY.md). The 1554 prior reviewed IDs are excluded from all new review counts.

119 new full-body reviews were frozen with source hash and explicit findings in three domain checkpoints. 127 additional normalized/canonicalized IDs comprise all 119 new reviewed IDs and eight previously reviewed IDs. Retrieval alone is never review.

All 421 prior canonicalized IDs and 105 source profiles remain preserved, with their historical documents unchanged. The current 548 IDs use 19 shared-owner specifications and 158 explicit profiles. CAP-DEVICES is an existing architectural owner newly given a specification for device identity, lifecycle, configuration provenance and bounded monitoring acquisition. No new module per device subtype is created. Clinical decisions, prescribing and imaging interpretation retain their separate owners.

CAP-DEVICES data and testing gates have PARTIAL_EVIDENCE from a bounded record contract and negative-case checks. No production API, device programming, live physical-state confirmation, authenticated reviewer approval or clinical validation is established. All eight implementation gates require evidence and named approval before IMPLEMENTATION_READY. Current ready count remains zero.

Seven gap proposals retain VALIDATED/INTEGRATED documentation decisions with provenance; new decisions count zero. Clinical validation remains zero. Search candidates outside adjudicated cases remain pending.

Counts use 5175 originals. Unique requirements are distinct normalized source requirement strings per owner, not proven independent semantic atoms. Metadata and proposal fragments are counted separately. Audit work=(R+N+C)/(3×5175); this is not product readiness.
